NATICK, Mass.--(BUSINESS WIRE)--Aleta Biotherapeutics (‘Aleta’) and Cancer Research UK today announced a collaboration to advance the early phase clinical development of Aleta’s CAR-T cell ...

Breen, a state-licensed healthcare provider, supplied patients with the "Real Immunity Homeoprophylaxis Program," a series of oral pellets that are marketed as an alternative to vaccination but ...